Table 1 Main Demographic and clinical characteristics in 95 RA patients
From: The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis
Variables | Percentage |
|---|---|
Female | 83.1% (79) |
RF (+) | 70.1% (63/89) |
Steroid therapy | 72.6% (69) |
Methotrexate | 80% (76) |
Chloroquine | 63.1% (60) |
DMARDS | 35.7% (34) |
Tumor necrosis factor alpha inhibitor | 15.8% (15) |
|  | Mean ± SD |
Current Age (years) | 52.5 ± 12.4 |
Age at RA onset (years) | 44 ± 12.4 |
Duration of RA (years) | 9 ± 7.1 |
Swollen joints count | 4.9 ± 5.6 |
Patient global assessment (VAS) | 4.2 ± 2.7 |
Physician global assessment (VAS) | 4.5 ± 2.3 |
HAQ | 0.5 ± 0.6 |
DAS 28 | 3.7 ± 1.5 |
ESR (mm/hour) | 30.6 ± 21.1 |
CRP (mg/dl) | 0.9 ± 1.1 |